<b>Background/Objectives</b>: CLEC-2 (C-type lectin-like receptor 2), the newest discovered platelet receptor, is involved in platelet activation and aggregation, the inflammatory response, tumor growth, metastasis, and angiogenesis. The gene discussed is CLEC1B; the disease is neoplasm.